- 期刊
早期子宮內膜癌保守性治療的新知
Fertility- Sparing Treatment for Early Endometrial Cancer
摘要
子宮內膜癌的標準治療方式是分期手術。但患者如尚未完成生育，如何兼顧治療與生育，便顯得很重要。常用的保留生育的治療方法主要為口服黃體素，如予以me-droxyprogesterone acetate(MPA)或megestrol acetate(MA)，其它治療方法尚有GnRHa、釋放levonorgestrel的子宮內避孕器、芳香酶抑制劑、metformin、子宮鏡內膜切除，或合併上述方法。同時建議，患者在完成治療後，在3個月內便能懷孕，一旦完成生育，宜立即切除子宮，避免復發。
並列摘要
The standard treatment for endometrial cancer is staging operation. However, most young women with endometrial cancer have a strong desire to bear children. It is imperative to provide them with fertility-sparing options that will allow them the opportunity to get pregnant while at the same time provide them with adequate treatment of their cancer. The most common type of fertility-sparing management involves progestin via use of oral medroxyprogesterone acetate (MPA) or megestrol acetate (MA). Other therapies that have been evaluated include GnRH agonist, intrauterine devices (IUDs) releasing levonorgestrel, aromatase inhibitor, metformin, hysteroscopic tumor resection, or a combination of these therapies. It is recommended that patients attempt to conceive approximately 3 months after the completion of therapy. Hysterectomy is advisable after completion of childbirth, given the high recurrence rates after conservative treatment.
延伸閱讀
- 李耀泰、陳福民、郭宗正（2012）。子宮內膜癌保守性治療的檢視。中華民國婦癌醫學雜誌，(2012年2)，30-42。https://doi.org/10.7010/JGO.201210.0030
- 王銘志、吳孟浩、張國華、賴允亮、鍾昌宏、劉岱瑋、陳裕仁（1997）。早期子宮內膜癌的治療與預後因子。放射治療與腫瘤學，4(1)，17-22。https://doi.org/10.6316/TRO/199704(1)17
- 李耀泰、周松男、沈仁達（1988）。子宮內膜癌概論和早期癌的治療（一）。當代醫學，(172)，152-155。https://doi.org/10.29941/MT.198802.0017
- 李浩、顏明賢、何積泓（2020）。早期子宮內膜癌生育保留治療：個案討論。婦癌醫學期刊，(52)，33-35。https://www.airitilibrary.com/Article/Detail?DocID=P20150521002-202010-202012160009-202012160009-33-35
- 王鵬惠、莊其穆、顏明賢、趙灌中、吳香達（2012）。Hormonal Therapy for Advanced or Recurrent Endometrial Cancers。中華民國婦癌醫學雜誌，(2012年2)，54+56-64。https://doi.org/10.7010/JGO.201210.0054